These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19590950)

  • 1. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.
    Zhang H; Rakha EA; Ball GR; Spiteri I; Aleskandarany M; Paish EC; Powe DG; Macmillan RD; Caldas C; Ellis IO; Green AR
    Breast Cancer Res Treat; 2010 May; 121(1):41-51. PubMed ID: 19590950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer.
    Alshareeda AT; Rakha EA; Nolan CC; Ellis IO; Green AR
    Breast Cancer Res Treat; 2012 Jul; 134(2):519-29. PubMed ID: 22562177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer.
    Baker BG; Ball GR; Rakha EA; Nolan CC; Caldas C; Ellis IO; Green AR
    Breast Cancer Res Treat; 2013 Jan; 137(1):127-37. PubMed ID: 23208589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of basal cytokeratin expression in breast cancer.
    Alshareeda AT; Soria D; Garibaldi JM; Rakha E; Nolan C; Ellis IO; Green AR
    Breast Cancer Res Treat; 2013 May; 139(1):23-37. PubMed ID: 23588953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype.
    Habashy HO; Powe DG; Rakha EA; Ball G; Macmillan RD; Green AR; Ellis IO
    Breast Cancer Res Treat; 2010 Apr; 120(3):603-12. PubMed ID: 19495959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fatty acid-binding protein 7/RXRβ pathway enhances survival and proliferation in triple-negative breast cancer.
    Liu RZ; Graham K; Glubrecht DD; Lai R; Mackey JR; Godbout R
    J Pathol; 2012 Nov; 228(3):310-21. PubMed ID: 22322885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of WWOX expression in patients with breast cancer and its association with the basal-like phenotype.
    Wang X; Chao L; Ma G; Chen L; Zang Y; Sun J
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):271-8. PubMed ID: 20401669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status.
    Kaloshi G; Mokhtari K; Carpentier C; Taillibert S; Lejeune J; Marie Y; Delattre JY; Godbout R; Sanson M
    J Neurooncol; 2007 Sep; 84(3):245-8. PubMed ID: 17415524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.
    Rakha EA; El-Rehim DA; Paish C; Green AR; Lee AH; Robertson JF; Blamey RW; Macmillan D; Ellis IO
    Eur J Cancer; 2006 Dec; 42(18):3149-56. PubMed ID: 17055256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of fatty acid binding protein-7 correlates with basal-like subtype of breast cancer.
    Tang XY; Umemura S; Tsukamoto H; Kumaki N; Tokuda Y; Osamura RY
    Pathol Res Pract; 2010 Feb; 206(2):98-101. PubMed ID: 19608352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up.
    Asleh K; Won JR; Gao D; Voduc KD; Nielsen TO
    Breast Cancer Res Treat; 2018 Feb; 168(1):107-115. PubMed ID: 29159761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.
    Tan DS; Marchió C; Jones RL; Savage K; Smith IE; Dowsett M; Reis-Filho JS
    Breast Cancer Res Treat; 2008 Sep; 111(1):27-44. PubMed ID: 17922188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.
    Powe DG; Voss MJ; Habashy HO; Zänker KS; Green AR; Ellis IO; Entschladen F
    Breast Cancer Res Treat; 2011 Nov; 130(2):457-63. PubMed ID: 21298476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast.
    Gromov P; Espinoza JA; Talman ML; Honma N; Kroman N; Timmermans Wielenga V; Moreira JM; Gromova I
    PLoS One; 2014; 9(11):e112024. PubMed ID: 25389781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.
    O Leary PC; Penny SA; Dolan RT; Kelly CM; Madden SF; Rexhepaj E; Brennan DJ; McCann AH; Pontén F; Uhlén M; Zagozdzon R; Duffy MJ; Kell MR; Jirström K; Gallagher WM
    BMC Cancer; 2013 Apr; 13():175. PubMed ID: 23547718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
    Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
    Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DACH1: its role as a classifier of long term good prognosis in luminal breast cancer.
    Powe DG; Dhondalay GK; Lemetre C; Allen T; Habashy HO; Ellis IO; Rees R; Ball GR
    PLoS One; 2014; 9(1):e84428. PubMed ID: 24392136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
    Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
    J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.
    Fulford LG; Reis-Filho JS; Ryder K; Jones C; Gillett CE; Hanby A; Easton D; Lakhani SR
    Breast Cancer Res; 2007; 9(1):R4. PubMed ID: 17217540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.